meningococcal B vaccine (sanofi-aventis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemeningococcal B vaccine (sanofi-aventis)
Drug Alias NameNeisseria meningitidis strain B vaccine (sanofi-aventis)meninge B vaccine (sanofi pasteur)meningococcal B vaccine (sanofi pasteur)meninge B vaccine (sanofi-aventis)meningococcal B vaccine (Aventis Pasteur) +[6] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeisseriaceae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur SaSanofi
Active IndicationsN/A
Inactive IndicationsNeisseriaceae Infections

Other Information

ATC CodeN/A
Related LinksN/A